Premium
Implementation of precision medicine in clinical trials in thoracic oncology: Which are the hurdles?
Author(s) -
Scagliotti Giorgio V.
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31055
Subject(s) - medicine , precision medicine , pace , perspective (graphical) , lung cancer , medical physics , clinical trial , personalized medicine , clinical oncology , oncology , medline , intensive care medicine , cancer , bioinformatics , pathology , geodesy , artificial intelligence , computer science , political science , law , biology , geography
Precision medicine quite likely will be implemented at a different pace than originally hypothesized, but it is definitely the way to move forward. Even from a medical oncology perspective, a clear understanding of the changes in a molecular pathway and the timely application of a diagnostic assay are critical steps to ultimately deliver a better treatment choice to each individual patient with non–small cell lung cancer. See also pages 4800‐7.